Pfizer (NYSE:PFE) yield math back in focus after cancer drug miss, shares recover Friday

Pfizer (NYSE:PFE) yield math back in focus after cancer drug miss, shares recover Friday  TechStock²

Summary aggregated from TechStock²'s public RSS feed. The full reporting belongs to TechStock² — please read it on their site.